This article showcases our top picks for the best Neuroscience companies based in France. These startups and companies are taking a variety of approaches to innovating the Neuroscience industry, but are all exceptional companies well worth a follow.
We meticulously selected companies ranging from cutting-edge startups to established brands based on their outstanding performance in the following categories:
- Innovation: Innovative ideas, innovative route to market, innovative product
- Growth: Exceptional growth, exceptional growth strategy
- Management, diversity and/or societal impact
Top Neuroscience Startups based in France
Data sourced from Crunchbase and SemRush.
Pharnext: A biopharmaceutical company engaged in developing treatments for severe neurological diseases, Pharnext advances lead drugs PXT3003 and PXT864 through clinical trials, underpinned by orphan drug status and strategic partnerships.
Qynapse: AI Neuroimaging Platform Qynapse is transforming clinical trials and clinical care for brain disorders by enhancing the accuracy of neuroimaging analysis, and providing a new layer of precision in understanding the efficacy of treatments for conditions such as Alzheimer’s, multiple sclerosis, and Parkinson’s disease.
Horama: They develop gene therapies for rare inherited ocular diseases, focusing on pioneering scientific research to create effective treatments. Their commitment to innovation drives their mission to translate complex genetic insights into real-world applications, offering hope to patients with limited therapeutic options.
Open Mind Neurotechnologies: Offers VR+biometrics AI-based assessments and behavioural & emotional neuro training for corporates. Their solutions help individuals recognize and manage stress and emotions and adapt to changes to enhance workplace well-being and performance.
Pixyl: AI-powered brain image analysis for enhanced patient care, aiming to equip radiologists and clinicians with advanced AI technology that integrates into existing radiology workflows. Their solutions offer clinically actionable insights to improve patient outcomes and streamline care delivery processes.
Gaoma Therapeutics: A biotechnology company that develops therapeutic molecules for neurological and inflammatory diseases, GAOMA Therapeutics specializes in creating lipid derivative treatments, addressing the significant unmet need in epilepsy care, where existing medications often fail in efficacy and tolerance.
Axorus: A developer of neuro-electronic interfaces for therapeutic applications to increase health span. They are developing an Artificial Retina aiming to restore sight for people with damaged retinas (cones and rods).
Conscious Labs: Creators of next-gen brain sensing technology for head wearables, the company stands at the forefront with Pavion®, an innovative ionic polymer ideal for biosensor integration in wearables. Their ThinkPulse® system offers advanced EEG sensing capabilities, facilitating out-of-lab research.
AgenT: Develops the first blood diagnosis to detect Alzheimer’s years before the onset of the irreversible symptoms. They are on a mission to defeat this disease by targeting the silent phase, by combining multi-omics assays with advanced machine-learning techniques.
XXII GROUP: An innovation & deep tech company focused on virtual, augmented, and mixed reality, artificial intelligence, and neurosciences, XXII develops AI software for real-time video analysis in urban areas. They can detect and analyze a range of situations using city camera networks, enhancing safety and operational efficiency.
ICM – Brain & Spine Institute: A nonprofit translational neuroscience institute researching brain and spinal cord disorders, ICM brings together patients, doctors, and researchers to expedite the creation of new treatments.
Neuro-Sys: They Provide in-vitro and in-vivo neurodegenerative preclinical modelling services to life sciences organizations. Assists with pharmacological profiling, action mechanism studies, and regulatory submissions for CNS and PNS disorders. Supports transitions from drug discovery to preclinical and early clinical stages.
Yneuro: A Braintech startup reinventing entertainment uses EEG technology to create an immersive experience by analyzing brainwaves to gauge emotional responses and tailor content in real-time. With a focus on deep tech and AI, they craft personalized music experiences and are expanding their team at the forefront of neurotechnology.
By the way: If you’re a corporate or investor looking for exciting startups in a specific market for a potential investment or acquisition, check out our Startup Sourcing Service!
